Works by Koeppen, Hartmut


Results: 59
    1
    2
    3

    A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with orWithout the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.

    Published in:
    Oncologist, 2017, v. 22, n. 3, p. 264, doi. 10.1634/theoncologist.2016-0223
    By:
    • Bendell, Johanna C.;
    • Hochster, Howard;
    • Hart, Lowell L.;
    • Firdaus, Irfan;
    • Mace, Joseph R.;
    • McFarlane, Joshua J.;
    • Kozloff, Mark;
    • Catenacci, Daniel;
    • Hsu, Jessie J.;
    • Hack, Stephen P.;
    • Shames, David S.;
    • Phan, See‐Chun;
    • Koeppen, Hartmut;
    • Cohn, Allen L.
    Publication type:
    Article
    4

    Association of programmed death ligand‐1 (PD‐L1) expression with treatment outcomes in patients with BRAF mutation‐positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib.

    Published in:
    Pigment Cell & Melanoma Research, 2018, v. 31, n. 4, p. 516, doi. 10.1111/pcmr.12670
    By:
    • Wongchenko, Matthew J.;
    • Ribas, Antoni;
    • Dréno, Brigitte;
    • Ascierto, Paolo A.;
    • McArthur, Grant A.;
    • Gallo, Jorge D.;
    • Rooney, Isabelle A.;
    • Hsu, Jessie;
    • Koeppen, Hartmut;
    • Yan, Yibing;
    • Larkin, James
    Publication type:
    Article
    5
    6
    7
    8

    Profiling Cancer Gene Mutations in Clinical Formalin-Fixed, Paraffin-Embedded Colorectal Tumor Specimens Using Targeted Next-Generation Sequencing.

    Published in:
    Oncologist, 2014, v. 19, n. 4, p. 336, doi. 10.1634/theoncologist.2013-0180
    By:
    • Zhang, Liangxuan;
    • Chen, Liangjing;
    • Sah, Sachin;
    • Latham, Gary J.;
    • Patel, Rajesh;
    • Song, Qinghua;
    • Koeppen, Hartmut;
    • Tam, Rachel;
    • Schleifman, Erica;
    • Mashhedi, Haider;
    • Chalasani, Sreedevi;
    • Fu, Ling;
    • Sumiyoshi, Teiko;
    • Raja, Rajiv;
    • Forrest, William;
    • Hampton, Garret M.;
    • Lackner, Mark R.;
    • Hegde, Priti;
    • Jia, Shidong
    Publication type:
    Article
    9

    Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29655-0
    By:
    • Savill, Kristin M. Zimmerman;
    • Lee, Brian B.;
    • Oeh, Jason;
    • Lin, Jie;
    • Lin, Eva;
    • Chung, Wei-Jen;
    • Young, Amy;
    • Chen, Wennie;
    • Miś, Monika;
    • Mesh, Kathryn;
    • Eastham, Jeffrey;
    • Gnad, Florian;
    • Jiang, Zhaoshi;
    • Stawiski, Eric W.;
    • Haley, Benjamin;
    • Daemen, Anneleen;
    • Wang, Xiaojing;
    • Koeppen, Hartmut;
    • Modrusan, Zora;
    • Martin, Scott E.
    Publication type:
    Article
    10

    Decoding non-canonical mRNA decay by the endoplasmic-reticulum stress sensor IRE1α.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27597-7
    By:
    • Le Thomas, Adrien;
    • Ferri, Elena;
    • Marsters, Scot;
    • Harnoss, Jonathan M.;
    • Lawrence, David A.;
    • Zuazo-Gaztelu, Iratxe;
    • Modrusan, Zora;
    • Chan, Sara;
    • Solon, Margaret;
    • Chalouni, Cécile;
    • Li, Weihan;
    • Koeppen, Hartmut;
    • Rudolph, Joachim;
    • Wang, Weiru;
    • Wu, Thomas D.;
    • Walter, Peter;
    • Ashkenazi, Avi
    Publication type:
    Article
    11
    12

    Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34562-5
    By:
    • Cantley, Jennifer;
    • Ye, Xiaofen;
    • Rousseau, Emma;
    • Januario, Tom;
    • Hamman, Brian D.;
    • Rose, Christopher M.;
    • Cheung, Tommy K.;
    • Hinkle, Trent;
    • Soto, Leofal;
    • Quinn, Connor;
    • Harbin, Alicia;
    • Bortolon, Elizabeth;
    • Chen, Xin;
    • Haskell, Roy;
    • Lin, Eva;
    • Yu, Shang-Fan;
    • Del Rosario, Geoff;
    • Chan, Emily;
    • Dunlap, Debra;
    • Koeppen, Hartmut
    Publication type:
    Article
    13
    14

    Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.

    Published in:
    PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0185862
    By:
    • Merchant, Mark;
    • Moffat, John;
    • Schaefer, Gabriele;
    • Chan, Jocelyn;
    • Wang, Xi;
    • Orr, Christine;
    • Cheng, Jason;
    • Hunsaker, Thomas;
    • Shao, Lily;
    • Wang, Stephanie J.;
    • Wagle, Marie-Claire;
    • Lin, Eva;
    • Haverty, Peter M.;
    • Shahidi-Latham, Sheerin;
    • Ngu, Hai;
    • Solon, Margaret;
    • Eastham-Anderson, Jeffrey;
    • Koeppen, Hartmut;
    • Huang, Shih-Min A.;
    • Schwarz, Jacob
    Publication type:
    Article
    15
    16
    17
    18

    Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screening.

    Published in:
    Cancer Immunology, Immunotherapy, 2018, v. 67, n. 3, p. 471, doi. 10.1007/s00262-017-2098-4
    By:
    • Zhang, Xu-chao;
    • Cao, Xu;
    • Sun, Chun;
    • Xie, Zhi;
    • Guo, Jian-jun;
    • Yang, Jin-ji;
    • Yang, Xue-ning;
    • Dai, Hang-jun;
    • Li, Su-chun;
    • Xu, Xin-ran;
    • Zuo, Yun-xia;
    • Chen, Meng;
    • Koeppen, Hartmut;
    • He, Jing;
    • Kiermaier, Astrid;
    • Shames, David;
    • Cheng, Gang;
    • Wu, Yi-long
    Publication type:
    Article
    19
    20
    21

    Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 1, p. 21, doi. 10.1016/j.cllc.2021.05.007
    By:
    • Gadgeel, Shirish;
    • Hirsch, Fred R.;
    • Kerr, Keith;
    • Barlesi, Fabrice;
    • Park, Keunchil;
    • Rittmeyer, Achim;
    • Zou, Wei;
    • Bhatia, Namrata;
    • Koeppen, Hartmut;
    • Paul, Sarah M.;
    • Shames, David;
    • Yi, Jing;
    • Matheny, Christina;
    • Ballinger, Marcus;
    • McCleland, Mark;
    • Gandara, David R.
    Publication type:
    Article
    22
    23

    Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice.

    Published in:
    Nature Communications, 2017, v. 8, n. 2, p. 14572, doi. 10.1038/ncomms14572
    By:
    • Lau, Janet;
    • Cheung, Jeanne;
    • Navarro, Armando;
    • Lianoglou, Steve;
    • Haley, Benjamin;
    • Totpal, Klara;
    • Sanders, Laura;
    • Koeppen, Hartmut;
    • Caplazi, Patrick;
    • McBride, Jacqueline;
    • Chiu, Henry;
    • Hong, Rebecca;
    • Grogan, Jane;
    • Javinal, Vincent;
    • Yauch, Robert;
    • Irving, Bryan;
    • Belvin, Marcia;
    • Mellman, Ira;
    • Kim, Jeong M.;
    • Schmidt, Maike
    Publication type:
    Article
    24

    High cell-surface density of HER2 deforms cell membranes.

    Published in:
    Nature Communications, 2016, v. 7, n. 9, p. 12742, doi. 10.1038/ncomms12742
    By:
    • Chung, Inhee;
    • Reichelt, Mike;
    • Shao, Lily;
    • Akita, Robert W.;
    • Koeppen, Hartmut;
    • Rangell, Linda;
    • Schaefer, Gabriele;
    • Mellman, Ira;
    • Sliwkowski, Mark X.
    Publication type:
    Article
    25

    Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma.

    Published in:
    Nature Communications, 2016, v. 7, n. 8, p. 12624, doi. 10.1038/ncomms12624
    By:
    • Wallin, Jeffrey J.;
    • Bendell, Johanna C.;
    • Funke, Roel;
    • Sznol, Mario;
    • Korski, Konstanty;
    • Jones, Suzanne;
    • Hernandez, Genevive;
    • Mier, James;
    • He, Xian;
    • Hodi, F. Stephen;
    • Denker, Mitchell;
    • Leveque, Vincent;
    • Cañamero, Marta;
    • Babitski, Galina;
    • Koeppen, Hartmut;
    • Ziai, James;
    • Sharma, Neeraj;
    • Gaire, Fabien;
    • Chen, Daniel S.;
    • Waterkamp, Daniel
    Publication type:
    Article
    26
    27
    28

    Neuropilin-2 expression in cancer.

    Published in:
    Histopathology, 2012, v. 61, n. 3, p. 340, doi. 10.1111/j.1365-2559.2012.04224.x
    By:
    • Jubb, Adrian M;
    • Sa, Susan M;
    • Ratti, Navneet;
    • Strickland, Laura A;
    • Schmidt, Maike;
    • Callahan, Christopher A;
    • Koeppen, Hartmut
    Publication type:
    Article
    29

    Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19408-2
    By:
    • Desbois, Mélanie;
    • Udyavar, Akshata R.;
    • Ryner, Lisa;
    • Kozlowski, Cleopatra;
    • Guan, Yinghui;
    • Dürrbaum, Milena;
    • Lu, Shan;
    • Fortin, Jean-Philippe;
    • Koeppen, Hartmut;
    • Ziai, James;
    • Chang, Ching-Wei;
    • Keerthivasan, Shilpa;
    • Plante, Marie;
    • Bourgon, Richard;
    • Bais, Carlos;
    • Hegde, Priti;
    • Daemen, Anneleen;
    • Turley, Shannon;
    • Wang, Yulei
    Publication type:
    Article
    30
    31
    32
    33
    34
    35

    Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

    Published in:
    Nature, 2012, v. 487, n. 7408, p. 505, doi. 10.1038/nature11249
    By:
    • Wilson, Timothy R.;
    • Fridlyand, Jane;
    • Yan, Yibing;
    • Penuel, Elicia;
    • Burton, Luciana;
    • Chan, Emily;
    • Peng, Jing;
    • Lin, Eva;
    • Wang, Yulei;
    • Sosman, Jeff;
    • Ribas, Antoni;
    • Li, Jiang;
    • Moffat, John;
    • Sutherlin, Daniel P.;
    • Koeppen, Hartmut;
    • Merchant, Mark;
    • Neve, Richard;
    • Settleman, Jeff
    Publication type:
    Article
    36

    RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.

    Published in:
    Nature, 2010, v. 464, n. 7287, p. 431, doi. 10.1038/nature08833
    By:
    • Hatzivassiliou, Georgia;
    • Song, Kyung;
    • Yen, Ivana;
    • Brandhuber, Barbara J.;
    • Anderson, Daniel J.;
    • Alvarado, Ryan;
    • Ludlam, Mary J. C.;
    • Stokoe, David;
    • Gloor, Susan L.;
    • Vigers, Guy;
    • Morales, Tony;
    • Aliagas, Ignacio;
    • Liu, Bonnie;
    • Sideris, Steve;
    • Hoeflich, Klaus P.;
    • Jaiswal, Bijay S.;
    • Seshagiri, Somasekar;
    • Koeppen, Hartmut;
    • Belvin, Marcia;
    • Friedman, Lori S.
    Publication type:
    Article
    37

    P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 9, p. 606, doi. 10.1093/jnci/djt054
    By:
    • Ong, Christy C.;
    • Jubb, Adrian M.;
    • Jakubiak, Diana;
    • Zhou, Wei;
    • Rudolph, Joachim;
    • Haverty, Peter M.;
    • Kowanetz, Marcin;
    • Yan, Yibing;
    • Tremayne, Jarrod;
    • Lisle, Richard;
    • Harris, Adrian L.;
    • Friedman, Lori S.;
    • Belvin, Marcia;
    • Middleton, Mark R.;
    • Blackwood, Elizabeth M.;
    • Koeppen, Hartmut;
    • Hoeflich, Klaus P.
    Publication type:
    Article
    38

    Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancers.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60457-2
    By:
    • Lehrich, Brandon M.;
    • Delgado, Evan R.;
    • Yasaka, Tyler M.;
    • Liu, Silvia;
    • Cao, Catherine;
    • Liu, Yuqing;
    • Taheri, Mohammad N.;
    • Guan, Xiangnan;
    • Koeppen, Hartmut;
    • Singh, Sucha;
    • Meadows, Vik;
    • Liu, Jia-Jun;
    • Singh-Varma, Anya;
    • Krutsenko, Yekaterina;
    • Poddar, Minakshi;
    • Hitchens, T. Kevin;
    • Foley, Lesley M.;
    • Liang, Binyong;
    • Rialdi, Alex;
    • Rai, Ravi P.
    Publication type:
    Article
    39
    40

    Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.

    Published in:
    Nature, 2014, v. 515, n. 7528, p. 563, doi. 10.1038/nature14011
    By:
    • Herbst, Roy S.;
    • Gettinger, Scott N.;
    • Horn, Leora;
    • Lawrence, Donald P.;
    • Hodi, F. Stephen;
    • Soria, Jean-Charles;
    • Kowanetz, Marcin;
    • Fine, Gregg D.;
    • Rost, Sandra;
    • Leabman, Maya;
    • Xiao, Yuanyuan;
    • Mokatrin, Ahmad;
    • Koeppen, Hartmut;
    • Hegde, Priti S.;
    • Mellman, Ira;
    • Chen, Daniel S.;
    • Hamid, Omid;
    • Gordon, Michael S.;
    • Sosman, Jeffery A.;
    • McDermott, David F.
    Publication type:
    Article
    41
    42
    43
    44
    45

    Conformation-locking antibodies for the discovery and characterization of KRAS inhibitors.

    Published in:
    Nature Biotechnology, 2022, v. 40, n. 5, p. 769, doi. 10.1038/s41587-021-01126-9
    By:
    • Davies, Christopher W.;
    • Oh, Angela J.;
    • Mroue, Rana;
    • Steffek, Micah;
    • Bruning, John M.;
    • Xiao, Yang;
    • Feng, Siyu;
    • Jayakar, Sangeeta;
    • Chan, Emily;
    • Arumugam, Vidhyalakshmi;
    • Uribe, Sean Carlo;
    • Drummond, Jake;
    • Frommlet, Alexandra;
    • Lu, Cheng;
    • Franke, Yvonne;
    • Merchant, Mark;
    • Koeppen, Hartmut;
    • Quinn, John G.;
    • Malhotra, Sushant;
    • Do, Steve
    Publication type:
    Article
    46

    Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models.

    Published in:
    Nature Biotechnology, 2010, v. 28, n. 6, p. 585, doi. 10.1038/nbt.1640
    By:
    • Singh, Mallika;
    • Lima, Anthony;
    • Molina, Rafael;
    • Hamilton, Patricia;
    • Clermont, Anne C.;
    • Devasthali, Vidusha;
    • Thompson, Jennifer D.;
    • Cheng, Jason H.;
    • Reslan, Hani Bou;
    • Ho, Calvin C. K.;
    • Cao, Timothy C.;
    • Lee, Chingwei V.;
    • Nannini, Michelle A.;
    • Fuh, Germaine;
    • Carano, Richard A. D.;
    • Koeppen, Hartmut;
    • Yu, Ron X.;
    • Forrest, William F.;
    • Plowman, Gregory D.;
    • Johnson, Leisa
    Publication type:
    Article
    47
    48
    49
    50

    Automated tumor immunophenotyping predicts clinical benefit from anti‐PD‐L1 immunotherapy.

    Published in:
    Journal of Pathology, 2024, v. 263, n. 2, p. 190, doi. 10.1002/path.6274
    By:
    • Li, Xiao;
    • Eastham, Jeffrey;
    • Giltnane, Jennifer M;
    • Zou, Wei;
    • Zijlstra, Andries;
    • Tabatsky, Evgeniy;
    • Banchereau, Romain;
    • Chang, Ching‐Wei;
    • Nabet, Barzin Y;
    • Patil, Namrata S;
    • Molinero, Luciana;
    • Chui, Steve;
    • Harryman, Maureen;
    • Lau, Shari;
    • Rangell, Linda;
    • Waumans, Yannick;
    • Kockx, Mark;
    • Orlova, Darya;
    • Koeppen, Hartmut
    Publication type:
    Article